Report cover image

Europe Animal Healthcare Market, by Animal Type (Livestock {Bovine, Porcine, Poultry, and Other} and Companion {Canine, Feline, and Equine}), by Route of Administration (Oral, Topical, and Injectable {Subcutaneous Injections, Intramuscular Injections, Int

Publisher Coherent Market Insights
Published Oct 13, 2022
Length 195 Pages
SKU # CMI17490155

Description

Europe Animal Healthcare Market, by Animal Type (Livestock {Bovine, Porcine, Poultry, and Other} and Companion {Canine, Feline, and Equine}), by Route of Administration (Oral, Topical, and Injectable {Subcutaneous Injections, Intramuscular Injections, Intravenous Injections, Intra-peritoneal Injections, and Others}), by Indication (Infectious Diseases, Pain, Auto-immune Disease, and Others), and by Country (Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Animal healthcare includes veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics, and parasiticides, which are used in the treatment of diseases associated with the digestive system, immunological system, reproductive system, respiratory, and urinary system of animals. A rapid increase in the cases of zoonotic viral diseases and other animal-borne diseases can have adverse effects on farming and other occupation. Efficient animal healthcare can facilitate enhanced productivity of livestock to the farmers, as livestock animals provide a major protein source through meat and milk. Increasing public-private collaboration to increase awareness about efficient animal healthcare in Europe is expected to drive the Europe animal healthcare market growth.

Market Dynamics

Increasing product launches is responsible for the growth of the Europe animal healthcare market over the forecast period. For instance, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched Fencovis, a new vaccine to prevent calf diarrhea. Boehringer Ingelheim is expanding its bovine vaccine portfolio with the introduction of Fencovis, a vaccine for the prevention of calf diarrhea that provides passive immunity to calves via the cows' maternal colostrum. Calf diarrhea, often known as calf scour, is a symptom of a variety of gastrointestinal illnesses that affect newborn calves who have not yet been weaned. Neonatal calf's undeveloped immune system, which is unable to create its own antibodies, makes calf scour much more difficult to treat.

Key features of the study:
  • This report provides an in-depth analysis of the Europe animal healthcare market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the Europe animal healthcare market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc., Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The Europe animal healthcare market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe animal healthcare market
Detailed Segmentation:
  • Europe Animal Healthcare Market, By Animal Type:
  • Livestock
  • Bovine
  • Porcine
  • Poultry
  • Other
  • Companion
  • Canine
  • Feline
  • Equine
  • Europe Animal Healthcare Market, By Route of Administration:
  • Oral
  • Topical
  • Injectable
  • Subcutaneous Injections
  • Intramuscular Injections
  • Intravenous Injections
  • Intra-peritoneal Injections
  • Others
  • Europe Animal Healthcare Market, By Indication:
  • Infectious Diseases
  • Pain
  • Auto-immune Disease
  • Others
  • Europe Animal Healthcare Market, By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Company Profiles
  • Merck & Co., Inc.*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Virbac
  • Dechra Pharmaceuticals Plc.
  • Vetoquinol S.A.
  • Zoetis Inc.
  • Ceva Santé Animale
  • Bayer AG
  • Elanco
  • Evonik Industries AG
  • Archer Daniels Midland Company
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

195 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Animal Type
Market Snapshot, By Route of Administration
Market Snapshot, By Indication
Market Snapshot, By Country
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
PEST Analysis
4. Europe Animal Healthcare Market- Impact of Coronavirus (Covid-19) Pandemic
Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market
5. Europe Animal Healthcare Market, By Animal Type, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Livestock
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Bovine
Porcine
Poultry
Other
Companion
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Canine
Feline
Equine
6. Europe Animal Healthcare Market, By Route of Administration, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Oral
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Topical
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Injectable
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
7. Europe Animal Healthcare Market, By Indication, 2017 – 2030, (US$ Million)
Overview
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2017 – 2030
Segment Trends
Infectious Diseases
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Pain
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Autoimmune Diseases
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
8. Europe Animal Healthcare Market, By Country, 2017 – 2030, (US$ Million)
Introduction
Market Share Analysis, By Country, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Country, 2017–2030
Country al Trends
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
9. Competitive Landscape
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Virbac
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Dechra Pharmaceuticals Plc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Vetoquinol S.A.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Zoetis Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Ceva Santé Animale
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Elanco
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Evonik Industries AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Archer Daniels Midland Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
10. Section
Research Methodology
About Us
*Browse 17 market data tables and 31 figures on "Europe Animal Healthcare Market” – Europe forecast to 2030

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us